4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-18-005806
Options or other derivatives
- CEO acquired 220,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LEONARD JOHN M. · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-25 | Grant or award : show line 1 in the form Stock Option (right to buy) | +220,000 | 220,000 | D |
Loading xslF345X03/doc4.xml…